Metabolomic Fingerprinting for the Detection of Early-Stage Lung Cancer: From the Genome to the Metabolome
The five-year survival rate of lung cancer patients is very low, mainly because most newly diagnosed patients present with locally advanced or metastatic disease. Therefore, early diagnosis is key to the successful treatment and management of lung cancer. Unfortunately, early detection methods of lu...
Main Authors: | Jean-François Haince, Philippe Joubert, Horacio Bach, Rashid Ahmed Bux, Paramjit S. Tappia, Bram Ramjiawan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/3/1215 |
Similar Items
-
Liquid Biopsy in Lung Cancer Screening: The Contribution of Metabolomics. Results of A Pilot Study
by: Sandeep Singhal, et al.
Published: (2019-07-01) -
A High-Performing Plasma Metabolite Panel for Early-Stage Lung Cancer Detection
by: Lun Zhang, et al.
Published: (2020-03-01) -
Metabolomic investigation of urinary extracellular vesicles for early detection and screening of lung cancer
by: Qinsi Yang, et al.
Published: (2023-05-01) -
The Ability of Metabolomics to Discriminate Non-Small-Cell Lung Cancer Subtypes Depends on the Stage of the Disease and the Type of Material Studied
by: Tomasz Kowalczyk, et al.
Published: (2021-07-01) -
Metabolomic Profiling in Lung Cancer: A Systematic Review
by: Daniela Madama, et al.
Published: (2021-09-01)